JP2007511463A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2007511463A5 JP2007511463A5 JP2006522051A JP2006522051A JP2007511463A5 JP 2007511463 A5 JP2007511463 A5 JP 2007511463A5 JP 2006522051 A JP2006522051 A JP 2006522051A JP 2006522051 A JP2006522051 A JP 2006522051A JP 2007511463 A5 JP2007511463 A5 JP 2007511463A5
- Authority
- JP
- Japan
- Prior art keywords
- component
- luminal surface
- agent
- vascular endothelium
- transport agent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003795 chemical substances by application Substances 0.000 claims 22
- 210000003989 endothelium vascular Anatomy 0.000 claims 15
- 239000012216 imaging agent Substances 0.000 claims 10
- 210000004323 caveolae Anatomy 0.000 claims 5
- 206010028980 Neoplasm Diseases 0.000 claims 4
- 230000003511 endothelial effect Effects 0.000 claims 4
- 210000001519 tissue Anatomy 0.000 claims 4
- 230000002792 vascular Effects 0.000 claims 4
- 239000003814 drug Substances 0.000 claims 3
- 241000700605 Viruses Species 0.000 claims 2
- 201000011510 cancer Diseases 0.000 claims 2
- 230000004807 localization Effects 0.000 claims 2
- 238000004519 manufacturing process Methods 0.000 claims 2
- 239000002872 contrast media Substances 0.000 claims 1
- 238000001514 detection method Methods 0.000 claims 1
- 238000003384 imaging method Methods 0.000 claims 1
- 239000003446 ligand Substances 0.000 claims 1
- 230000005291 magnetic effect Effects 0.000 claims 1
- 230000003211 malignant effect Effects 0.000 claims 1
- 108020004707 nucleic acids Proteins 0.000 claims 1
- 102000039446 nucleic acids Human genes 0.000 claims 1
- 150000007523 nucleic acids Chemical class 0.000 claims 1
- 230000008520 organization Effects 0.000 claims 1
- 230000005298 paramagnetic effect Effects 0.000 claims 1
- 108090000765 processed proteins & peptides Proteins 0.000 claims 1
- 102000004196 processed proteins & peptides Human genes 0.000 claims 1
- 108090000623 proteins and genes Proteins 0.000 claims 1
- 230000002285 radioactive effect Effects 0.000 claims 1
- 229940124597 therapeutic agent Drugs 0.000 claims 1
- 239000013598 vector Substances 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US10/631,481 US20040115128A1 (en) | 1995-09-08 | 2003-07-31 | Targeting endothelium for tissue-specific delivery of agents |
| PCT/US2004/024448 WO2005012489A2 (en) | 2003-07-31 | 2004-07-29 | Targeting endothelium for tissue-specific delivery of agents |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2007511463A JP2007511463A (ja) | 2007-05-10 |
| JP2007511463A5 true JP2007511463A5 (https=) | 2007-09-13 |
Family
ID=34115771
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006522051A Pending JP2007511463A (ja) | 2003-07-31 | 2004-07-29 | 作用物質の組織特異的送達のための内皮の標的化 |
Country Status (6)
| Country | Link |
|---|---|
| US (2) | US20040115128A1 (https=) |
| EP (1) | EP1664272A4 (https=) |
| JP (1) | JP2007511463A (https=) |
| AU (1) | AU2004261988B2 (https=) |
| CA (1) | CA2537899A1 (https=) |
| WO (1) | WO2005012489A2 (https=) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5139058B2 (ja) | 2004-06-02 | 2013-02-06 | シドニー キンメル キャンサー センター | 新形成または新生脈管構造の検出、画像化および処置のための血管標的 |
| EP1755686A2 (en) * | 2004-06-02 | 2007-02-28 | Sidney Kimmel Cancer Center | Imaging and therapeutic agents targeting proteins expressed on endothelial cell surface |
| US7810718B2 (en) * | 2005-05-12 | 2010-10-12 | Cubic Corporation | Variable thickness data card body |
| US20070106271A1 (en) | 2005-11-09 | 2007-05-10 | Searete Llc, A Limited Liability Corporation | Remote control of substance delivery system |
| US9474712B2 (en) * | 2005-11-09 | 2016-10-25 | Gearbox, Llc | In situ reaction device |
| US20070106277A1 (en) * | 2005-11-09 | 2007-05-10 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Remote controller for substance delivery system |
| US9067047B2 (en) * | 2005-11-09 | 2015-06-30 | The Invention Science Fund I, Llc | Injectable controlled release fluid delivery system |
| US8936590B2 (en) * | 2005-11-09 | 2015-01-20 | The Invention Science Fund I, Llc | Acoustically controlled reaction device |
| US8273071B2 (en) | 2006-01-18 | 2012-09-25 | The Invention Science Fund I, Llc | Remote controller for substance delivery system |
| US8083710B2 (en) | 2006-03-09 | 2011-12-27 | The Invention Science Fund I, Llc | Acoustically controlled substance delivery device |
| US8273075B2 (en) | 2005-12-13 | 2012-09-25 | The Invention Science Fund I, Llc | Osmotic pump with remotely controlled osmotic flow rate |
| US8992511B2 (en) | 2005-11-09 | 2015-03-31 | The Invention Science Fund I, Llc | Acoustically controlled substance delivery device |
| US20080140057A1 (en) | 2006-03-09 | 2008-06-12 | Searete Llc, A Limited Liability Corporation Of State Of The Delaware | Injectable controlled release fluid delivery system |
| EP3019203A4 (en) | 2013-07-09 | 2017-04-26 | President and Fellows of Harvard College | Endothelial cell genes and uses thereof |
| WO2015006501A2 (en) * | 2013-07-09 | 2015-01-15 | President And Fellows Of Harvard College | Microvessel endothelial cell surface markers and uses thereof |
| EP3596108A4 (en) | 2017-03-15 | 2020-12-23 | Pandion Operations, Inc. | TARGETED IMMUNOTOLERANCE |
| US10676516B2 (en) | 2017-05-24 | 2020-06-09 | Pandion Therapeutics, Inc. | Targeted immunotolerance |
| US10174092B1 (en) | 2017-12-06 | 2019-01-08 | Pandion Therapeutics, Inc. | IL-2 muteins |
| US10946068B2 (en) | 2017-12-06 | 2021-03-16 | Pandion Operations, Inc. | IL-2 muteins and uses thereof |
| USRE50550E1 (en) | 2017-12-06 | 2025-08-26 | Pandion Operations, Inc. | IL-2 muteins and uses thereof |
| BR112021023345A2 (pt) | 2019-05-20 | 2022-02-01 | Pandion Operations Inc | Imunotolerância com alvo em madcam |
| EP4107187A4 (en) | 2020-02-21 | 2024-07-03 | Pandion Operations, Inc. | TISSUE-TARGETED IMMUNOTOLERANCE WITH A CD39 EFFECTOR |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5602005A (en) * | 1989-03-03 | 1997-02-11 | The University Of Virginia Alumni Patents Foundation | Primate intra-acrosomal sperm antigen for use in a contraceptive vaccine |
| US5776427A (en) * | 1992-03-05 | 1998-07-07 | Board Of Regents, The University Of Texas System | Methods for targeting the vasculature of solid tumors |
| US5281700A (en) * | 1992-08-11 | 1994-01-25 | The Regents Of The University Of California | Method of recovering endothelial membrane from tissue and applications thereof |
| US5776770A (en) * | 1995-09-08 | 1998-07-07 | Beth Israel Deaconess Medical Center | Isolation and uses of caveolae |
| US20030008819A1 (en) * | 1995-09-08 | 2003-01-09 | Schnitzer Jan E. | Targeting endothelium for tissue-specific delivery of agents |
| EP0848614B1 (en) * | 1995-09-08 | 2006-04-26 | Beth Israel Deaconess Medical Center | Isolation of microdomains of caveolae and gpi-anchored proteins |
-
2003
- 2003-07-31 US US10/631,481 patent/US20040115128A1/en not_active Abandoned
-
2004
- 2004-07-29 AU AU2004261988A patent/AU2004261988B2/en not_active Ceased
- 2004-07-29 JP JP2006522051A patent/JP2007511463A/ja active Pending
- 2004-07-29 EP EP04779493A patent/EP1664272A4/en not_active Withdrawn
- 2004-07-29 WO PCT/US2004/024448 patent/WO2005012489A2/en not_active Ceased
- 2004-07-29 CA CA002537899A patent/CA2537899A1/en not_active Abandoned
-
2007
- 2007-02-27 US US11/711,404 patent/US20070160531A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2007511463A5 (https=) | ||
| Sun et al. | In vivo targeting and imaging of atherosclerosis using multifunctional virus-like particles of simian virus 40 | |
| Krumpe et al. | The use of phage-displayed peptide libraries to develop tumor-targeting drugs | |
| Han et al. | Targeting fibronectin for cancer imaging and therapy | |
| Laakkonen et al. | Homing peptides as targeted delivery vehicles | |
| Tandle et al. | Tumor vasculature‐targeted delivery of tumor necrosis factor‐α | |
| Toh et al. | Phase 2 trial of linifanib (ABT‐869) in patients with unresectable or metastatic hepatocellular carcinoma | |
| Chang et al. | A novel peptide enhances therapeutic efficacy of liposomal anti-cancer drugs in mice models of human lung cancer | |
| Von Zur Muhlen et al. | Visualization of activated platelets by targeted magnetic resonance imaging utilizing conformation-specific antibodies against glycoprotein IIb/IIIa | |
| Carr | Hepatocellular carcinoma: diagnosis and treatment | |
| JP2005523687A5 (https=) | ||
| Ji et al. | Targeted delivery of interferon‐α to hepatitis B virus‐infected cells using T‐cell receptor‐like antibodies | |
| He et al. | A novel peptide probe for imaging and targeted delivery of liposomal doxorubicin to lung tumor | |
| JP2012019790A5 (https=) | ||
| Bu et al. | Bimodal liquid biopsy for cancer immunotherapy based on peptide engineering and nanoscale analysis | |
| JP2009197002A5 (https=) | ||
| ES2363044T3 (es) | Péptidos específicos para las metástasis y sus aplicaciones en diagnóstico y terapéuticas. | |
| JP2017507936A5 (https=) | ||
| Ma et al. | Anti-tumor effects of the peptide TMTP1-GG-D (KLAKLAK) 2 on highly metastatic cancers | |
| Wu et al. | Peptide‐mediated liposomal drug delivery system targeting tumor blood vessels in anticancer therapy | |
| JP2015513083A5 (https=) | ||
| Jung et al. | Characterization of hepatocellular carcinoma cell lines based on cell adhesion molecules | |
| Feng et al. | Initial experience of anti-PD1 therapy with nivolumab in advanced hepatocellular carcinoma | |
| JP2008501701A5 (https=) | ||
| US20180289844A1 (en) | Methods and compositions for cancer diagnosis |